Neogen Stock

Neogen Equity

The The Equity of Neogen (NEOG) as of Jun 16, 2026 is 2.07 TT USD.In the previous year, The Equity was 3.14 TT USD — a change of -34.12% (lower).

Equity

2.07 TTUSD

YoY

-34.12%

Last updated:

In 2026, Neogen's equity was 2.07 TT USD, a -34.12% increase from the 3.14 TT USD equity in the previous year.

Access this data via the Eulerpool API

Neogen Stock analysis

What does Neogen do? Neogen Corp is a leading provider of food safety and animal health solutions based in Lansing, Michigan, USA. The company was founded in 1982 by James Herbert and initially focused on the development and manufacturing of rapid tests for the dairy industry. Since then, Neogen has become an internationally operating company with over 25 subsidiaries and 1,800 employees. Neogen's business model is based on providing solutions for safe and healthy food supply and animal husbandry. The company operates in two main divisions: Food Safety and Animal Safety. Within these divisions, Neogen offers a wide range of test kits, diagnostic tools, information management software, and other products that help minimize the risk of food poisoning and improve the health of livestock. In the Food Safety division, Neogen offers a variety of test kits that allow food producers and retailers to quickly and easily detect various types of contaminants in food. These include tests for salmonella, E. coli, listeria, and mycotoxins. The company also provides tools for monitoring water quality and verifying cleaning and disinfection processes in food processing plants. In the Animal Safety division, Neogen also offers an extensive range of diagnostic tools to improve the health of livestock. The tests include infectious diseases such as brucellosis, BSE (mad cow disease), mastitis, and leukemia. Additionally, Neogen provides tools for animal identification and animal health data management. Neogen has also specialized in the development of technologies to improve animal health and nutrition, such as probiotics and supplements for livestock. Another focus of Neogen is the development of information management software that enables food producers and retailers to streamline the process of food safety and quality. The software allows companies to track tests, analyze data, and implement best practices to minimize the risk of food poisoning. In recent years, Neogen has also increasingly focused on the global market, especially the Asian market. The company has subsidiaries in various parts of the world, including Europe, Latin America, and Asia. Neogen works closely with local regulatory authorities to offer its products in accordance with local requirements. In conclusion, Neogen Corp is a leading provider of food safety and animal health solutions, focusing on the development and manufacturing of test kits, diagnostic tools, and information management software. The company has experienced impressive growth in recent decades and is now operating internationally. With its commitment to safe and healthy food supply and animal husbandry, Neogen sets industry standards. Neogen is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Neogen's Equity

Neogen's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Neogen's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Neogen's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Neogen's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Neogen’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Neogen stock

The Equity of Neogen amounted to 3.14 TT USD 2.07 TT

Access this data via the Eulerpool API

Balance Sheet — Neogen

All Key Metrics — Neogen